These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16958564)

  • 1. Risperidone in the management of disruptive behavior disorders.
    Pandina GJ; Aman MG; Findling RL
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):379-92. PubMed ID: 16958564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.
    Haas M; Karcher K; Pandina GJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):337-45. PubMed ID: 18759643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of risperidone in children with disruptive behavioural disorders.
    Duhig MJ; Saha S; Scott JG
    J Paediatr Child Health; 2013 Jan; 49(1):19-26. PubMed ID: 22050179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function with long-term risperidone in children and adolescents with disruptive behavior disorder.
    Pandina GJ; Zhu Y; Cornblatt B
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):749-56. PubMed ID: 20035593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients.
    Croonenberghs J; Fegert JM; Findling RL; De Smedt G; Van Dongen S;
    J Am Acad Child Adolesc Psychiatry; 2005 Jan; 44(1):64-72. PubMed ID: 15608545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2008; 69 Suppl 4():9-14. PubMed ID: 18533763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and safety profile of risperidone in a sample of children and adolescents.
    Margari L; Matera E; Craig F; Petruzzelli MG; Palmieri VO; Pastore A; Margari F
    Int Clin Psychopharmacol; 2013 Jul; 28(4):177-83. PubMed ID: 23689836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
    Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
    Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the role of risperidone in the treatment of disruptive behavior disorders.
    Shatkin JP
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):377-8. PubMed ID: 16958563
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone and cognitive function in children with disruptive behavior disorders.
    Pandina GJ; Bilder R; Harvey PD; Keefe RS; Aman MG; Gharabawi G
    Biol Psychiatry; 2007 Aug; 62(3):226-34. PubMed ID: 17210137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ.
    Aman M; Buitelaar J; Smedt GD; Wapenaar R; Binder C
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):220-32. PubMed ID: 15910206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.
    Findling RL; Aman MG; Eerdekens M; Derivan A; Lyons B;
    Am J Psychiatry; 2004 Apr; 161(4):677-84. PubMed ID: 15056514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotics for behavioral problems in children.
    Shafiq S; Pringsheim T
    Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety, and tolerability.
    Reyes M; Croonenberghs J; Augustyns I; Eerdekens M
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):260-72. PubMed ID: 16768634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
    Roke Y; Buitelaar JK; Boot AM; Tenback D; van Harten PN
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):432-9. PubMed ID: 23234586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and sexual maturation during long-term treatment with risperidone.
    Dunbar F; Kusumakar V; Daneman D; Schulz M
    Am J Psychiatry; 2004 May; 161(5):918-20. PubMed ID: 15121661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six months of treatment with risperidone may be associated with nonsignificant abnormalities of liver function tests in children and adolescents: a longitudinal, observational study from Turkey.
    Erdogan A; Karaman MG; Ozdemir E; Yurteri N; Tufan AE; Kurcer MA
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):407-13. PubMed ID: 20973711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review.
    Pringsheim T; Gorman D
    Can J Psychiatry; 2012 Dec; 57(12):722-7. PubMed ID: 23228230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.